TGTGInsighttelegram intelligenceLIVE / telegram public index
← GitHub Trends

TGINSIGHT SIMILAR POSTS

Find similar content

Source channel @githubtrending · Post #14962 · Jul 16

#typescript#ai#chatgpt#docsgpt#hacktoberfest#information_retrieval#language_model#llm#machine_learning#natural_language_processing#python#pytorch#rag#react#semantic_search#transformers#web_app DocsGPT is an open-source AI tool that helps you quickly find accurate answers from many types of documents and web sources without errors. It supports formats like PDF, DOCX, images, and integrates with websites, APIs, and chat platforms like Discord and Telegram. You can deploy it privately for security, customize it to fit your brand, and connect it to tools for advanced actions. This means you save time searching for information, get reliable answers with sources, and improve productivity whether you’re a developer, support team, or business user. It’s easy to set up and scales well for many users[2][3][4]. https://github.com/arc53/DocsGPT

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选
Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment